Moneycontrol
Last Updated : Jan 11, 2019 05:58 PM IST | Source: Moneycontrol.com

Jubilant Life Science Q3 PAT seen up 13.8% YoY to Rs. 241.8 cr: ICICI Direct

Net Sales are expected to increase by 17.8 percent Y-o-Y (up 7.4 percent Q-o-Q) to Rs. 2,436.5 crore, according to ICICI Direct.

Moneycontrol News @moneycontrolcom
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

ICICI Direct has come out with its third quarter (October-December’ 18) earnings estimates for the Healthcare sector. The brokerage house expects Jubilant Life Science to report net profit at Rs. 241.8 crore up 13.8% year-on-year (up 15.3% quarter-on-quarter).


Net Sales are expected to increase by 17.8 percent Y-o-Y (up 7.4 percent Q-o-Q) to Rs. 2,436.5 crore, according to ICICI Direct.


Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 15.8 percent Y-o-Y (up 7.2 percent Q-o-Q) to Rs. 482.5 crore.


Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

First Published on Jan 11, 2019 05:58 pm
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant